Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization

Vaccine

Volumn 18, Issue 18, 2000, Pages 1962-1968

  Lee, Alexander Y ^a   Polakos, Noelle K ^a   Otten, Gillis R ^a   Ulmer, Jeffrey B ^a   Houghton, Michael ^a   Paliard, Xavier ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

CTL; DNA immunization; HCV

Indexed keywords

CD8 ANTIGEN; DNA; EPITOPE; HEPATITIS C VACCINE; PLASMID DNA;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HEPATITIS C VIRUS; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPACIVIRUS; HEPATITIS C; IMMUNODOMINANT EPITOPES; INJECTIONS, INTRAMUSCULAR; LYMPHOCYTE COUNT; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED CBA; MICE, INBRED DBA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL VACCINES;

EID: 0033997840     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00486-7     Document Type: Article

References (26)

1. Alter M., Margolis H., Krawczynski K., et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327:(27):1992;1899-1905.
2. Resnick R., Koff R. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch. Intern. Med. 153:(14):1993;1672-1677.
3. Seeff L. Natural history of viral hepatitis, type C. Semin Gastrointest Dis. 6:(1):1995;20-27.
4. Tong M., el-Farra N., Reikes A., Co R. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332:(22):1995;1463-1466.
5. Hoofnagle J., di Bisceglie A. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:(5):1997;347-356.
6. Diepolder H., Zachoval R., Hoffmann R., et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:(8981):1995;1006-1007.
7. Missale G., Bertoni R., Lamonaca V., et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98:(3):1996;706-714.
8. Christie J., Healey C., Watson J., et al. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin. Exp. Immunol. 110:(1):1997;4-8.
9. Koziel M. The role of immune responses in the pathogenesis of hepatitis C virus infection. J. Viral Hepat. 4:(Suppl 2):1997;31-41.
10. Nelson D., Marousis C., Davis G., et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158:(3):1997;1473-1481.
11. Cooper S., Erickson A., Adams E., et al. Analysis of a successful immune response against hepatitis C virus. Immunity. 10:(4):1999;439-449.
12. Farci P, Bukh J, Purcell R. The quasispecies of hepatitis C virus and the host immune response. 1997;19(1);5-26.
13. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., Vandepol S. Rapid evolution of RNA genomes. Science. 215:(4540):1982;1577-1585.
14. Shirai M., Akatsuka T., Pendleton C., et al. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 66:(7):1992;4098-4106.
15. Shirai M., Okada H., Nishioka M., et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:(5):1994;3334-3442.
16. Shirai M., Chen M., Arichi T., et al. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. J. Infect. Dis. 173:(1):1996;24-31.
17. Bruna-Romero O., Lasarte J., Wilkinson G., et al. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology. 25:(2):1997;470-477.
18. Choo Q., Richman K., Han J., et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:(6):1991;2451-2455.
19. Waldrop S., Pitcher C., Peterson D., Maino V., Picker L. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99:(7):1997;1739-1750.
20. Murali-Krishna K., Altman J., Suresh M., et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:(2):1998;177-187.
21. Paliard X., Doe B., Walker C. The T cell repertoire primed by antiviral vaccination is influenced by self-tolerance. Cell Immunol. 188:(1):1998;73-79.
22. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:(6324):1991;290-296.
23. Scherer M., Ignatowicz L., Pullen A., Kappler J., Marrack P. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. J. Exp. Med. 182:(5):1995;1493-1504.
24. Flynn K., Belz G., Altman J., Ahmed R., Woodland D., Doherty P. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 8:(6):1998;683-691.
25. Butz E., Bevan M. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity. 8:(2):1998;167-175.
26. McMichael A., O'Callaghan C. A new look at T cells. J. Exp. Med. 187:(9):1998;1367-1371.